ARCHIVES

Opioid Pain Reliever Approved With Risk Reduction Plan

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Steckel Urges AACI to seek Increase In Core Funding

July 17, 1981

ETP-ALL May Be Linked To Acute Myeloid Leukemia

January 27, 2012

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

Ford To Resubmit Budget Slash Of $125 Million For NCI

January 3, 1975

Dept. of Defense opens program announcements for prostate cancer research.

December 10, 2004

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991